Send us a text)
How Can Digital Pathology Workflows Stay Compliant and Efficient?
In this episode of the Digital Pathology Podcast, I sit down with Scott Randall, Senior Application Specialist at Hamamatsu (Hamamatsu NanoZoomer)), and Amanda Coble, Senior Director of Product for Proscia (Proscia’s Website)), to discuss the critical role of compliance, interoperability, and efficiency in digital pathology workflows.
🔬 Key Topics Covered:
- [00:00:00] Introduction and Initial Challenges in Digital Pathology Compliance
- **[00:01:00] **Guest Introductions: Meet Scott and Amanda
- [00:03:00] Hamamatsu’s FDA Clearance Journey: Lessons Learned
- **[00:06:00] **Proscia’s Path to FDA Clearance and Partnering with Hamamatsu
- [00:10:00] How Digital Pathology Systems Maintain Compliance
- [00:14:00] The Advantages of Open Architecture in Digital Pathology
- [00:18:00] Overcoming Challenges in Slide Scanning and Logistics
- [00:22:00] Phases of Digital Pathology Adoption and Future-Proofing Labs
- [00:27:00] The Role of AI and Automation in Digital Pathology Workflows
- [00:32:00] Advice for Vendors Looking to Build Compliant Digital Pathology Solutions
- [00:38:00] Final Thoughts: The Future of Interoperability and Compliance
🩺 Why This Episode Matters:Regulatory approval in digital pathology isn’t just about scanning slides—it’s about building a seamless, interoperable workflow that ensures accuracy, efficiency, and compliance. Hamamatsu and Proscia were among the first companies to successfully achieve FDA clearance for their integrated solutions, setting the stage for future innovations in AI-powered digital pathology.
Episode Resources:
- Learn more about Hamamatsu’s NanoZoomer series: Hamamatsu NanoZoomer)
- Discover Proscia’s AI-driven pathology software: Proscia’s Website)
- Read the DPP Blog on selecting the right whole-slide scanner: Choosing the Right Whole-Slide Scanner for Your Pathology Lab)
Support the show)
Become a Digital Pathology Trailblazer get the "Digital Pathology 101" FREE E-book and join us!)
